Table 1

Genes silenced by promoter DNA hypermethylation and histone H3 hypoacetylation in AML

NameSymbolGb accFold change (mRNA) Aza/untreatedH3 acetylation (log fold change) AML/CD34Adjusted PDirection of change
Peroxiredoxin 2 PRDX2 L19185 2.3075 −1.3056 .0059 H3Ac in AML decreased 
Trefoil factor 3 (intestinal) TFF3 NM_003226 3.1108 −1.3698 .0204 H3Ac in AML decreased 
MHC, class I, A HLA-A AI923492 2.2161 −1.2975 .0137 H3Ac in AML decreased 
MHC, class I, A HLA-A AA573862 2.8716 −1.2975 .0137 H3Ac in AML decreased 
Catenin (cadherin-associated protein), delta 1 CTNND1 NM_001331 2.0985 −1.0649 .0291 H3Ac in AML decreased 
TIMP metallopeptidase inhibitor 1 TIMP1 NM_003254 3.5313 −1.1289 .0179 H3Ac in AML decreased 
Cylindromatosis (turban tumor syndrome) CYLD BF516433 2.9026 −1.0625 .0286 H3Ac in AML decreased 
Nuclear factor, IL- 3 regulated NFIL3 NM_005384 2.0471 −1.0622 .0403 H3Ac in AML decreased 
TNF (ligand) superfamily, member 10 /// TNF (ligand) superfamily, member 10 TNFSF10 NM_003810 2.4509 −1.0049 .0380 H3Ac in AML decreased 
TNF (ligand) superfamily, member 10 /// TNF (ligand) superfamily, member 10 TNFSF10 NM_003810 2.7388 −1.0049 .0380 H3Ac in AML decreased 
ATP-binding cassette, sub-family G (WHITE), member 1 ABCG1 NM_004915 2.2372 −1.0052 .0126 H3Ac in AML decreased 
Protein tyrosine phosphatase, receptor type, C PTPRC AI809341 2.4576 −0.8651 .0425 H3Ac in AML decreased 
SH3 domain binding glutamic acid-rich protein like 3 /// SH3 domain binding glutamic acid-rich protein like 3 SH3BGRL3 NM_031286 2.4592 −1.1272 .0203 H3Ac in AML decreased 
NameSymbolGb accFold change (mRNA) Aza/untreatedH3 acetylation (log fold change) AML/CD34Adjusted PDirection of change
Peroxiredoxin 2 PRDX2 L19185 2.3075 −1.3056 .0059 H3Ac in AML decreased 
Trefoil factor 3 (intestinal) TFF3 NM_003226 3.1108 −1.3698 .0204 H3Ac in AML decreased 
MHC, class I, A HLA-A AI923492 2.2161 −1.2975 .0137 H3Ac in AML decreased 
MHC, class I, A HLA-A AA573862 2.8716 −1.2975 .0137 H3Ac in AML decreased 
Catenin (cadherin-associated protein), delta 1 CTNND1 NM_001331 2.0985 −1.0649 .0291 H3Ac in AML decreased 
TIMP metallopeptidase inhibitor 1 TIMP1 NM_003254 3.5313 −1.1289 .0179 H3Ac in AML decreased 
Cylindromatosis (turban tumor syndrome) CYLD BF516433 2.9026 −1.0625 .0286 H3Ac in AML decreased 
Nuclear factor, IL- 3 regulated NFIL3 NM_005384 2.0471 −1.0622 .0403 H3Ac in AML decreased 
TNF (ligand) superfamily, member 10 /// TNF (ligand) superfamily, member 10 TNFSF10 NM_003810 2.4509 −1.0049 .0380 H3Ac in AML decreased 
TNF (ligand) superfamily, member 10 /// TNF (ligand) superfamily, member 10 TNFSF10 NM_003810 2.7388 −1.0049 .0380 H3Ac in AML decreased 
ATP-binding cassette, sub-family G (WHITE), member 1 ABCG1 NM_004915 2.2372 −1.0052 .0126 H3Ac in AML decreased 
Protein tyrosine phosphatase, receptor type, C PTPRC AI809341 2.4576 −0.8651 .0425 H3Ac in AML decreased 
SH3 domain binding glutamic acid-rich protein like 3 /// SH3 domain binding glutamic acid-rich protein like 3 SH3BGRL3 NM_031286 2.4592 −1.1272 .0203 H3Ac in AML decreased 
Close Modal

or Create an Account

Close Modal
Close Modal